GlassScriptPhysician profile
Karun Badwal
NPI 1003268483
$1,631.42
in general payments reported to CMS, 2019-2025
9 companies · $87.37 in 2025
The $87.37 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $595 · 2023: $479 · 2024: $202 · 2025: $87.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.33 | 2021-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $325.42 | 2021-2023 | Xarelto |
| Pfizer INC. | $259.87 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $231.54 | 2021-2024 | Dificid, Zerbaxa, Recarbrio |
| Astrazeneca Pharmaceuticals LP | $142.22 | 2021-2023 | Farxiga, Lokelma |
| Novartis Pharmaceuticals Corporation | $94.88 | 2021-2023 | |
| Abbvie INC. | $85.62 | 2022-2024 | |
| Boston Scientific Corporation | $59.48 | 2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.06 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karun Badwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.